GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and ...

Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing ALT-B4 ...

BioPharma SHAKTI aims to revolutionize biologics by promoting non-animal models for safer and more effective drug development ...

Commercial launch of AlbuFree DX recombinant human albumin by Proliant Health & Biologicals using Dyadic's production platform, with Dyadic eligible to receive a share of profits from product salesExp ...

U.S. Joint Forces are deployed and stationed across the world in various climates, terrains, and situations. They need to be ...

A chemical manufacturing facility near Dutchtown is positioning itself for long-term growth as it navigates federal approvals ...

Neion Bio’s Raptor™ platform utilizes cutting-edge genetic engineering to harness nature’s most efficient molecular factories ...

Since I stepped into the President’s role in June 2025, our focus has been very clear: to accelerate Dyadic International, ...

Every clinical trial is built on the promise that the risk is justified by the strength of the evidence supporting it.

Cloud-Clone drives technological innovation for obesity research, providing validated targets for precise matching of ...

Scale-up involves increasing pump sizes, reactor volumes, and flow rates—but the process control logic and system ...

New drug manufacturer Neion Bio has emerged from stealth after incubating a novel way to cook up biologic drugs. | The new ...